Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. The company is also involved in the production of encapsulated powders; and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milk products, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. The company was founded in 1988 and is headquartered in Altona North, Australia.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+61-3-83475000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$76.68 million
Profitability
Miscellaneous
Employees39
Next Earnings DateN/A
OptionableNot Optionable
Clover (ASX:CLV) Frequently Asked Questions
What is Clover's stock symbol?
Clover trades on the ASX under the ticker symbol "CLV."
How often does Clover pay dividends? What is the dividend yield for Clover?
Clover announced a Final dividend on Monday, September 23rd. Shareholders of record on Wednesday, November 20th will be given a dividend of 0.018 per share on Wednesday, November 20th. This represents a yield of 0.64%. The ex-dividend date is Tuesday, October 29th. View Clover's Dividend History.
Has Clover been receiving favorable news coverage?
Media coverage about CLV stock has trended negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Clover earned a media sentiment score of -2.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Clover.
Who are some of Clover's key competitors?
Some companies that are related to Clover include Enerplus (ERF), Advanced Medical Solutions Group (AMS), CRH Medical (CRH), CRH Medical (CRHM), CRH Medical (CRHM), Bovie Medical (BVX), Bovie Medical (BVX), TransEnterix (TRXC), Tristel (TSTL), InfuSystem (INFU), SDI (SDI), Impression Healthcare (IHL), TSO3 (TOS), Milestone Scientific (MLSS) and Daxor (DXR).
What other stocks do shareholders of Clover own?
Who are Clover's key executives?
Clover's management team includes the folowing people:
- Mr. Peter J. Davey MBA, gradDip Bus., GAICD, CEO, MD & Exec. Director
- Mr. Paul A. Sherman C.A., M.B.A., B.Bus, CA, MBA, CFO & Company Sec.
- Mr. David Pierotti, Operations Mang.
- Dr. C. Patch, Chief Innovation Officer
- S. Poothong, Chief Commercial Officer
What is Clover's stock price today?
One share of CLV stock can currently be purchased for approximately A$2.99.
How big of a company is Clover?
What is Clover's official website?
How can I contact Clover?
Clover's mailing address is U 35E 1 International Dr, MELBOURNE, VIC 3049, Australia. The company can be reached via phone at +61-3-83475000.
MarketBeat Community Rating for Clover (ASX CLV)
MarketBeat's community ratings are surveys of what our community members think about Clover and other stocks. Vote "Outperform" if you believe CLV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLV will underperform the S&P 500 over the long term. You may vote once every thirty days.
